Cargando…
560 Dolichyl Phosphate Dependent Mechanism of Exacerbations in Asthma: P-Glycoprotein Overexpression and E-Cadherin Loss
BACKGROUND: In asthma exacerbations there is a functional hyporesponsiveness of glucocorticoid (FHG) receptors (GR) on T cells, disbalance in activity of IL-2, IL-4, IL-10 and E-cadherin loss. Dolichyl phosphate (DolP) plays an essential role in cytokine synthesis, in constancy of glycoproteins of t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512589/ http://dx.doi.org/10.1097/01.WOX.0000411675.19290.f9 |
_version_ | 1782251755292065792 |
---|---|
author | Kuznecova, Galina Kuznecovs, Ivans S. Joksta, Inese Kuznecovs, Sergejs |
author_facet | Kuznecova, Galina Kuznecovs, Ivans S. Joksta, Inese Kuznecovs, Sergejs |
author_sort | Kuznecova, Galina |
collection | PubMed |
description | BACKGROUND: In asthma exacerbations there is a functional hyporesponsiveness of glucocorticoid (FHG) receptors (GR) on T cells, disbalance in activity of IL-2, IL-4, IL-10 and E-cadherin loss. Dolichyl phosphate (DolP) plays an essential role in cytokine synthesis, in constancy of glycoproteins of the GR and E-cadherin expression. The present study was carried out to estimate the role of DolP in mechanism of exacerbations. METHODS: The samples obtained from 82 patients with with frequent exacerbations (APFE group) (median duration > 14 day a year) and 83 patients without exacerbations over 12 months (APWE group). Dolichyl phosphate was defined in T-cells. Soluble E-cadherin was measured with ELISA in sputum and in bronchial epithelial cells (BEC). The intensity of glycoprotein synthesis in IL-2, IL-4, IL-10 and GR was estimated based on the number of starting glycosylation complexes (SGC) and radioimmunoassay. RESULTS: In APWE group Blood Dol concentration was 221.6 + 15.4 ng/mL and urinary Dol concentration was 16.2 + 4.5 mkg/mmol. In APFE group blood Dol was increased up to 4 times making up 455.2 + 31.7 ng/mL and urinary Dol concentration was increased up to 400%, making up to 32.2 + 4.7 mkg/mmol and 2 times in comparison with APWE group. APFE group had 3 to 4 times higher E-cadherin levels in sputum than APWE group. The synthesis of DolP was 7.5-fold decreased in T-lymphocytes in APFE group. APFE group T-cells membrans contain 5.6 to 6.4% of P-glycoprotein-170 as a marker of FHR receptors which differ from APWE ones in Pgp content by 9 to 11 times. DolP in the concentration 10 to 6 M aid 7 to 9-fold reducing P-glycoprotein-170 content in membranes of APFE T-cells to 0,4 to 0,6% and prevent loss of E-cadherin in BEC. T-cells from APFE group cultivated with corticosteroids and Polyprenol restore the possibility to induce IL-10 synthesis in vitro, enhanced the expression of alpha GP isoforms and made these cells more responsive to steroids. CONCLUSIONS: DolP level and N-glycosylation dirorders could correlate with P-glycoprotein overexpression in FHG in T-cells and E-cadherin loss in EC in asthma exacerbations. Dol detection in blood and urine opens up possibilities for exacerbations control and management. |
format | Online Article Text |
id | pubmed-3512589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | World Allergy Organization Journal |
record_format | MEDLINE/PubMed |
spelling | pubmed-35125892012-12-21 560 Dolichyl Phosphate Dependent Mechanism of Exacerbations in Asthma: P-Glycoprotein Overexpression and E-Cadherin Loss Kuznecova, Galina Kuznecovs, Ivans S. Joksta, Inese Kuznecovs, Sergejs World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: In asthma exacerbations there is a functional hyporesponsiveness of glucocorticoid (FHG) receptors (GR) on T cells, disbalance in activity of IL-2, IL-4, IL-10 and E-cadherin loss. Dolichyl phosphate (DolP) plays an essential role in cytokine synthesis, in constancy of glycoproteins of the GR and E-cadherin expression. The present study was carried out to estimate the role of DolP in mechanism of exacerbations. METHODS: The samples obtained from 82 patients with with frequent exacerbations (APFE group) (median duration > 14 day a year) and 83 patients without exacerbations over 12 months (APWE group). Dolichyl phosphate was defined in T-cells. Soluble E-cadherin was measured with ELISA in sputum and in bronchial epithelial cells (BEC). The intensity of glycoprotein synthesis in IL-2, IL-4, IL-10 and GR was estimated based on the number of starting glycosylation complexes (SGC) and radioimmunoassay. RESULTS: In APWE group Blood Dol concentration was 221.6 + 15.4 ng/mL and urinary Dol concentration was 16.2 + 4.5 mkg/mmol. In APFE group blood Dol was increased up to 4 times making up 455.2 + 31.7 ng/mL and urinary Dol concentration was increased up to 400%, making up to 32.2 + 4.7 mkg/mmol and 2 times in comparison with APWE group. APFE group had 3 to 4 times higher E-cadherin levels in sputum than APWE group. The synthesis of DolP was 7.5-fold decreased in T-lymphocytes in APFE group. APFE group T-cells membrans contain 5.6 to 6.4% of P-glycoprotein-170 as a marker of FHR receptors which differ from APWE ones in Pgp content by 9 to 11 times. DolP in the concentration 10 to 6 M aid 7 to 9-fold reducing P-glycoprotein-170 content in membranes of APFE T-cells to 0,4 to 0,6% and prevent loss of E-cadherin in BEC. T-cells from APFE group cultivated with corticosteroids and Polyprenol restore the possibility to induce IL-10 synthesis in vitro, enhanced the expression of alpha GP isoforms and made these cells more responsive to steroids. CONCLUSIONS: DolP level and N-glycosylation dirorders could correlate with P-glycoprotein overexpression in FHG in T-cells and E-cadherin loss in EC in asthma exacerbations. Dol detection in blood and urine opens up possibilities for exacerbations control and management. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3512589/ http://dx.doi.org/10.1097/01.WOX.0000411675.19290.f9 Text en Copyright © 2012 by World Allergy Organization |
spellingShingle | Abstracts of the XXII World Allergy Congress Kuznecova, Galina Kuznecovs, Ivans S. Joksta, Inese Kuznecovs, Sergejs 560 Dolichyl Phosphate Dependent Mechanism of Exacerbations in Asthma: P-Glycoprotein Overexpression and E-Cadherin Loss |
title | 560 Dolichyl Phosphate Dependent Mechanism of Exacerbations in Asthma: P-Glycoprotein Overexpression and E-Cadherin Loss |
title_full | 560 Dolichyl Phosphate Dependent Mechanism of Exacerbations in Asthma: P-Glycoprotein Overexpression and E-Cadherin Loss |
title_fullStr | 560 Dolichyl Phosphate Dependent Mechanism of Exacerbations in Asthma: P-Glycoprotein Overexpression and E-Cadherin Loss |
title_full_unstemmed | 560 Dolichyl Phosphate Dependent Mechanism of Exacerbations in Asthma: P-Glycoprotein Overexpression and E-Cadherin Loss |
title_short | 560 Dolichyl Phosphate Dependent Mechanism of Exacerbations in Asthma: P-Glycoprotein Overexpression and E-Cadherin Loss |
title_sort | 560 dolichyl phosphate dependent mechanism of exacerbations in asthma: p-glycoprotein overexpression and e-cadherin loss |
topic | Abstracts of the XXII World Allergy Congress |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512589/ http://dx.doi.org/10.1097/01.WOX.0000411675.19290.f9 |
work_keys_str_mv | AT kuznecovagalina 560dolichylphosphatedependentmechanismofexacerbationsinasthmapglycoproteinoverexpressionandecadherinloss AT kuznecovsivanss 560dolichylphosphatedependentmechanismofexacerbationsinasthmapglycoproteinoverexpressionandecadherinloss AT jokstainese 560dolichylphosphatedependentmechanismofexacerbationsinasthmapglycoproteinoverexpressionandecadherinloss AT kuznecovssergejs 560dolichylphosphatedependentmechanismofexacerbationsinasthmapglycoproteinoverexpressionandecadherinloss |